These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38355180)

  • 1. Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.
    Coe A; Gunn J; Allnutt Z; Kaylor-Hughes C
    BMJ Open; 2024 Feb; 14(2):e078179. PubMed ID: 38355180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General Practice Patients' Experiences and Perceptions of the WiserAD Structured Web-Based Support Tool for Antidepressant Deprescribing: Protocol for a Mixed Methods Case Study With Realist Evaluation.
    Coe A; Gunn J; Kaylor-Hughes C
    JMIR Res Protoc; 2022 Dec; 11(12):e42526. PubMed ID: 36580362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.
    Kelly D; Graffi J; Noonan M; Green P; McFarland J; Hayes P; Glynn L
    BMJ Open; 2021 Apr; 11(4):e046054. PubMed ID: 33820792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice.
    Wallis KA; Donald M; Horowitz M; Moncrieff J; Ware RS; Byrnes J; Thrift K; Cleetus M; Panahi I; Zwar N; Morgan M; Freeman C; Scott I
    Trials; 2023 Sep; 24(1):615. PubMed ID: 37770893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
    Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
    Stuijt PJC; Heringa M; van Dijk L; Faber A; Burgers JS; Feenstra TL; Taxis K; Denig P
    BMC Prim Care; 2024 Jun; 25(1):210. PubMed ID: 38862899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial.
    Kendrick T; Geraghty AWA; Bowers H; Stuart B; Leydon G; May C; Yao G; O'Brien W; Glowacka M; Holley S; Williams S; Zhu S; Dewar-Haggart R; Palmer B; Bell M; Collinson S; Fry I; Lewis G; Griffiths G; Gilbody S; Moncrieff J; Moore M; Macleod U; Little P; Dowrick C
    Trials; 2020 May; 21(1):419. PubMed ID: 32448374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant deprescribing: State of the art and recommendations-A literature overview.
    Romagnoli A; Zovi A; Santoleri F; Lasala R
    Eur J Clin Pharmacol; 2024 Mar; 80(3):417-433. PubMed ID: 38189859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review.
    Coe A; Kaylor-Hughes C; Fletcher S; Murray E; Gunn J
    BMJ Open; 2021 Sep; 11(9):e052547. PubMed ID: 34489296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE trial).
    Weiss K; Pichierri G; Grischott T; Groth S; Neuner-Jehle S
    BMJ Open; 2023 Sep; 13(9):e075828. PubMed ID: 37730388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol.
    Hølmkjær P; Holm A; Overbeck G; Rozing MP
    Trials; 2022 May; 23(1):410. PubMed ID: 35578351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the
    Coe A; Gunn J; Fletcher S; Murray E; Kaylor-Hughes C
    Prim Health Care Res Dev; 2023 Feb; 24():e16. PubMed ID: 36843079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing considerations for older people in general practice.
    Quek HW; Page A; Potter K; Etherton-Beer C
    Aust J Gen Pract; 2023 Apr; 52(4):173-180. PubMed ID: 37021442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.